JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

Search

Idera Pharmaceuticals Inc

Suletud

0

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Idera Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. okt 2025, 22:47 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22. okt 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22. okt 2025, 21:20 UTC

Tulu

Correction to IBM 3Q Sales Jump Article

22. okt 2025, 20:57 UTC

Tulu

SAP Posts Higher 3Q Revenue, Operating Profit

22. okt 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. okt 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22. okt 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22. okt 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22. okt 2025, 23:15 UTC

Tulu

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22. okt 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22. okt 2025, 22:02 UTC

Tulu

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22. okt 2025, 21:59 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22. okt 2025, 21:58 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22. okt 2025, 21:57 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22. okt 2025, 21:56 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22. okt 2025, 21:47 UTC

Omandamised, ülevõtmised, äriostud

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22. okt 2025, 21:47 UTC

Tulu

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22. okt 2025, 21:47 UTC

Omandamised, ülevõtmised, äriostud

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22. okt 2025, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22. okt 2025, 21:45 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22. okt 2025, 21:45 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22. okt 2025, 21:28 UTC

Market Talk
Tulu

Correction to Alcoa Tariff Market Talk

22. okt 2025, 21:25 UTC

Tulu

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22. okt 2025, 21:17 UTC

Tulu

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22. okt 2025, 21:09 UTC

Market Talk
Tulu

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22. okt 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22. okt 2025, 20:59 UTC

Tulu

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22. okt 2025, 20:51 UTC

Tulu

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. okt 2025, 20:44 UTC

Tulu

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Võrdlus sarnastega

Hinnamuutus

Idera Pharmaceuticals Inc Prognoos

Finantsandmed

$

help-icon Live chat